SCHEMBL6328747

SCHEMBL6328747

Cc1ccc(NC(=O)c2nc(-c3ccc(OC(C)(C)C(=O)O)cc3)sc2-c2ccc(Cl)cc2)cc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 15/20 0.54
▸ PPARD Q03181 6/20 0.54
▸ MAPT P10636 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ PPARG P37231 3/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ XDH P47989 1/20 0.43
▸ PDE5A O76074 1/20 0.42
▸ MAP4K4 O95819 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ MINK1 Q8N4C8 1/20 0.42
▸ FABP2 P12104 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6329127 0.93 PPARA (0.56) PPARAPPARDMAPTMEN1KMT2A
SCHEMBL6327988 0.91 PPARA (0.51) PPARAPPARDMAPTMEN1KMT2A
SCHEMBL6325562 0.89 PPARA (0.55) PPARAPPARDMAPTLMNAMEN1
SCHEMBL6325756 0.88 PPARA (0.54) PPARAPPARDMAPTMEN1KMT2A
SCHEMBL6329096 0.87 PPARA (0.56) PPARAPPARDMAPTMEN1KMT2A
SCHEMBL6333235 0.86 PPARA (0.67) PPARAPPARDMAPTMEN1KMT2A
SCHEMBL6334662 0.83 PPARA (0.47) PPARAPPARDMAPTMEN1KMT2A
SCHEMBL6328831 0.81 PPARA (0.57) PPARAPPARDMAPTLMNAMEN1
SCHEMBL6328138 0.80 PPARA (0.56) PPARAPPARDPPARG
Trifluoroacetic Acid SCHEMBL6325797 0.80 PPARA (0.49) PPARAPPARDMAPTLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION 2005-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity GPR119, EGLN3, PC PPARA 49/4885PPARD 55/4885MAPT 3022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback